Cargando…

Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers

BACKGROUND: Treatment with apremilast has recently demonstrated clinically meaningful improvement in moderate hidradenitis suppurativa (HS). OBJECTIVE: To evaluate the change in expression of inflammatory markers in lesional skin of HS patients receiving apremilast 30 mg twice daily (n = 15) for 16 ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vossen, A.R.J.V., van der Zee, H.H., Davelaar, N., Mus, A.M.C., van Doorn, M.B.A., Prens, E.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Acne ‐ Rosacea
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590194/ https://www.ncbi.nlm.nih.gov/pubmed/30451329 http://dx.doi.org/10.1111/jdv.15354

Ejemplares similares

A novel nicastrin mutation in a three‐generation Dutch family with hidradenitis suppurativa: a search for functional significance
por: Vossen, A.R.J.V., et al.
Publicado: (2020)

HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
por: Peris, K., et al.
Publicado: (2019)

Primary alterations during the development of hidradenitis suppurativa
por: Dajnoki, Z., et al.
Publicado: (2021)

Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials
por: van der Zee, H.H., et al.
Publicado: (2019)

Real‐world effectiveness of adalimumab in patients with moderate‐to‐severe hidradenitis suppurativa: the 1‐year SOLACE study
por: Gulliver, W., et al.
Publicado: (2021)

Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidradenitis suppurativa patients: a prospective single centre study
por: Prens, L.M., et al.
Publicado: (2019)

Improvement in Hidradenitis Suppurativa and quality of life in patients treated with adalimumab: Real‐world results from the HARMONY Study
por: Hafner, A., et al.
Publicado: (2021)

The influence of exposome on acne
por: Dréno, B., et al.
Publicado: (2018)

Creation of a severity index for hidradenitis suppurativa that includes a validated quality‐of‐life measure: the HIDRAscore
por: Marzano, A.V., et al.
Publicado: (2020)

Papulopustular rosacea and rosacea‐like demodicosis: two phenotypes of the same disease?
por: Forton, F.M.N., et al.
Publicado: (2018)

Acne relapses: impact on quality of life and productivity
por: Dreno, B., et al.
Publicado: (2019)

Baseline patient‐reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice
por: Kimball, A.B., et al.
Publicado: (2020)

The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin (IL)‐17A, IL‐12/23 and CD20 in hidradenitis suppurativa: an ex vivo study
por: Vossen, A.R.J.V., et al.
Publicado: (2019)

Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR‐γ selective topical retinoid, in patients with moderate facial and truncal acne
por: Blume‐Peytavi, U., et al.
Publicado: (2019)

Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study
por: Vossen, Allard R. J. V., et al.
Publicado: (2017)

Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model
por: Vossen, Allard R. J. V., et al.
Publicado: (2018)

Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group
por: Zouboulis, C.C., et al.
Publicado: (2018)

Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa
por: Aarts, Pim, et al.
Publicado: (2021)

Novel cytokine and chemokine markers of hidradenitis suppurativa reflect chronic inflammation and itch
por: Vossen, Allard R. J. V., et al.
Publicado: (2018)

High and discordant prevalences of clinical and sonographic enthesitis in patients with hidradenitis suppurativa
por: van Straalen, K.R., et al.
Publicado: (2020)

Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis
por: Gudjonsson, Johann E., et al.
Publicado: (2020)

Management of mild hidradenitis suppurativa: our greatest challenge yet
por: van der Zee, H.H., et al.
Publicado: (2021)

Successful treatment of hidradenitis suppurativa and Crohn's disease with combined guselkumab and apremilast
por: Agud‐Dios, Manuel, et al.
Publicado: (2022)

Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study
por: Prens, L.M., et al.
Publicado: (2021)

Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study
por: Bouwman, Klasiena, et al.
Publicado: (2022)

Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches
por: Ardon, C.B., et al.
Publicado: (2020)

Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
por: Gulliver, Wayne, et al.
Publicado: (2016)

Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander?
por: van Straalen, K. R., et al.
Publicado: (2022)

Damage in hidradenitis suppurativa: receiving the deserved attention
por: Aarts, Pim, et al.
Publicado: (2022)

Validity and Reliability of Two Digital Wound Measurement Tools after Surgery in Patients with Hidradenitis Suppurativa
por: Aarts, Pim, et al.
Publicado: (2023)

Guidelines for Qualifications of Neurodiagnostic Personnel: A Joint Position Statement of the American Clinical Neurophysiology Society, the American Association of Neuromuscular & Electrodiagnostic Medicine, the American Society of Neurophysiological Monitoring, and ASET—The Neurodiagnostic Society
por: López, Jaime R., et al.
Publicado: (2023)

Cura tu acné : dietas y nuevos tratamientos
por: Hoehn, Gustave H.
Publicado: (1997)

Apremilast for the treatment of hidradenitis suppurativa associated with psoriatic arthritis in multimorbid patients: Case report and review of literature
por: Garcovich, Simone, et al.
Publicado: (2020)

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022)

Clindamycin-Benzoyl Peroxide Gel Compared with Clindamycin Lotion for Hidradenitis Suppurativa: A Randomized Controlled Assessor-Blinded Intra-Patient Pilot Study
por: Aarts, Pim, et al.
Publicado: (2023)

Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials
por: Jemec, G.B.E., et al.
Publicado: (2019)

Vulvar cancer in hidradenitis suppurativa
por: Vergeldt, T.F.M., et al.
Publicado: (2022)

Bases para la atención farmacéutica del acné vulgar /
por: Sánchez Alonso, Francisco
Publicado: (2000)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e86oujgjmr0b2j6a4e8su2s99t